New Jersey Senate Bill S517

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

Impact

If enacted, S517 would amend existing laws related to the processing of prescriptions by pharmacies in New Jersey. This change is anticipated to eliminate any financial disincentives for healthcare providers and patients who favor electronic prescriptions. It reinforces the push towards utilizing technology in healthcare, which could lead to better record-keeping and potentially lower costs for patients. The bill aims to align the processing fees for electronic prescriptions with those of written prescriptions, ensuring fairness in how pharmacists charge for the service.

Summary

S517 is a legislative bill introduced in New Jersey that aims to prohibit pharmacies from charging additional fees for processing prescriptions transmitted electronically or by telephone. The bill is rooted in the belief that electronic prescriptions are more efficient than traditional written prescriptions. By not imposing extra fees, the bill encourages the adoption of electronic methods for prescription transmission, which could improve accessibility for patients and streamline the pharmacy operation process.

Contention

Debate around S517 could arise regarding the balance between maintaining pharmacy revenues and promoting electronic prescriptions. Some pharmacists may argue that the ability to charge fees for processing varied types of prescriptions helps sustain their business model, particularly given the differences in processing electronic versus written prescriptions. Opponents of additional fees might assert that such charges serve as barriers to utilizing modern methods that facilitate faster and more reliable care, potentially hurting overall healthcare delivery in New Jersey.